pdufa date for tirzepatide Today we shared that the U.S. FDA has accepted our Biologics License Application (BLA) an investigational gene therapy for Glycogen Storage Disease Type Ia (GSDIa) for priority review. This milestone means RTTNews | BIG WEEK AHEAD

Diabetes with comorbid depression: role of SSRI in better glycemic control

The difference between a smart purchase and an expensive mistake often comes down to understanding how compounded tirzepatide pricing actually works

Our highly trained and experienced primary care providers can help you determine if semaglutide is the right choice for your weight management goals

Pathogenesis A nodular regenerative response to prior or continuous hepatocellular damage

Most traditional NSAIDs block both COX-1 and COX-2 enzymes, which is why they can cause side effects like stomach upset or ulcers in addition to providing relief from pain and inflammation